Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature
- 1 September 1997
- journal article
- case report
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (6) , 2737-2738
- https://doi.org/10.1016/s0041-1345(97)00576-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact on donor-specific immune modulationTransplantation Proceedings, 1997
- Pancreas transplantation with enteric drainage under tacrolimus induction therapyTransplantation Proceedings, 1997
- FK 506 in kidney transplantation: Results of the U.S.A. randomized comparative phase III studyTransplantation Proceedings, 1997
- TACROLIMUS RESCUE THERAPY FOR RENAL ALLOGRAFT REJECTION-FIVE-YEAR EXPERIENCE1Transplantation, 1997
- TACROLIMUS THERAPY FOR REFRACTORY ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1996
- A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1Transplantation, 1996
- THE RELATIVE EFFECTS OF FK506 AND CYCLOSPORINE ON SHORT- AND LONG-TERM KIDNEY GRAFT SURVIVAL1,2,3Transplantation, 1995
- TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN-12 IN PANCREATIC β-CELLTransplantation, 1995